Launches a 90-Day Diabetes Management programme for People with Type 2 Diabetes
Roche Diabetes Care India (RDC) and Fitterfly Healthtech, India’s leading Digital Therapeutics (DTx) company have partnered to co-create a 90-day diabetes management programme for people with type 2 diabetes.
This programme is aimed at enhancing therapy adherence and improving outcomes, and bringing true relief to people with diabetes.
The program is designed to give instant insights on blood sugar, in-depth assessments and personalised plans for nutrition, fitness and wellness to provide best-in-class outcomes.
This is best suited for individuals with newly diagnosed type 2 diabetes, new and fast-changing prescriptions on insulin or those who have spotted new symptoms indicating long-term complications of diabetes.
“We are very excited to embark on this journey with Roche Diabetes Care India, who share our outcome-focused approach towards the treatment of diabetes. The programme is designed to study the effects of various food groups on blood sugars with our unique meal-mapping technology. We help supplement medical treatment with nutrition, fitness and stress management solutions that have been proven to reduce blood sugar. The members of the programme will be able to benefit from the accuracy and personalised approach of the programme bridging the important gap of lifestyle management and long-term behaviour change that is crucial to medical management prescribed by doctors.”
Dr. Arbinder Singal, Co-founder & CEO of Fitterfly added,
“Creating a robust and supportive eco-system plays a vital role in enabling effective diabetes management. This includes forming a combination of monitoring, therapy, diet and lifestyle guidance. Technology acts as an enabler here by bringing in advanced analytics and by enhancing the reach of this ecosystem such that more people are within the circle of care. We are proud to partner with Fitterfly, who not only has the right technology but also shares our purpose of improving access to diabetes care. Through this programme we believe we can generate real-world evidence to showcase the importance of comprehensive care in enhancing therapy adherence and improving outcomes.”
Omar Sherief Mohammad, Cluster Head, India Middle East and Africa, Roche Diabetes Care said,
Fitterfly was selected as part of Roche’s Startup Creasphere APAC programme from among >40 startups in digital health for its clinical validation, personalised, and 360° approach to type 2 diabetes management.
About Fitterfly:
Fitterfly is a smart, personal digital therapeutic solution that is an anytime, anywhere companion for patients to truly achieve their health goals.
The company offers clinically validated, digital-led therapy that connects patients, health coaches, and healthcare providers in meaningful ways to enable sustainable behavior change that is at the core of good health.
Fitterfly achieves transformational outcomes for patients with personalized, data and coaching-led behavior change via Vogital (voice and digital) touchpoints with a user-centric app.
The programmes are based on glocally accepted, evidence-based protocols, and cutting-edge research.
Fitterfly’s current product suite includes scientific and hyper-personalized DTx programmes for Type 2 diabetes, prediabetes, and obesity.
They are the preferred digital therapeutic partner for many doctors, hospitals, organizations like pharma companies, corporates, and medical device companies.
Fitterfly was cofounded by Dr. Arbinder Singal- CEO and Shailesh Gupta- COO
About Roche Diabetes Care:
Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years.
More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.
About Roche:
